Showing results (191-200 of 349) with videos related to
Sort By:
Pageof 35
Leukemia & Lymphoma|March 5, 2014
The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern eraChadi Nabhan, Briseis Aschebrook-Kilfoy, Brian C-H Chiu, et al.Leukemia|November 28, 2019
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphomaDashnamoorthy Ravi, Saheli Sarkar, Sneha Purvey, et al.The American Journal of Drug and Alcohol Abuse|February 1, 1995
Presenting problems of substance abusers in treatment: implications for service delivery and attritionH A Siegal, J H Fisher, R C Rapp, et al.Infection|February 15, 2013
Management of a rifampicin-resistant meningococcal infection in a teenagerD Delaune, D Andriamanantena, A Mérens, et al.Travel Medicine and Infectious Disease|July 24, 2014
Prevention of infectious diseases during military deployments: a review of the French armed forces strategyR Michel, J P Demoncheaux, M A Créach, et al.Fortschritte Der Neurologie-Psychiatrie|February 28, 2015
[The Basel Interview for Psychosis (BIP): structure, reliability and validity]A Riecher-Rössler, T Ackermann, M Uttinger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cellsSavita Bhalla, Sriram Balasubramanian, Kevin David, et al.Journal of Cancer Survivorship : Research and Practice|August 27, 2024
Survivorship preparedness and activation among survivors of lymphomaSharon L Manne, Shawna V Hudson, Dena O'Malley, et al.British Journal of Haematology|April 26, 2014
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II studyAndrew M Evens, Mitchell R Smith, Izidore S Lossos, et al.Blood|September 25, 2004
Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cellsAndrew M Evens, Philip Lecane, Darren Magda, et al.Pageof 35